Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 05-2021 | 02-2021 | 11-2020 | 08-2020 | 05-2020 | |
| Sales | 204 | 192 | 296 | 134 | 81 |
| Cost of Goods | 60 | 31 | 64 | 13 | 20 |
| Gross Profit | 144 | 161 | 231 | 121 | 61 |
| Operating Expenses | 2,641 | 1,199 | 955 | 893 | 1,395 |
| Operating Income | -2,497 | -1,037 | -724 | -773 | -1,334 |
| Other Income | -70 | 1,456 | 11 | 1 | -57 |
| Pre-tax Income | -2,567 | 418 | -713 | -772 | -1,391 |
| Net Income Continuous | -2,567 | 418 | -713 | -772 | -1,391 |
| Net Income Discontinuous | 0 | -25 | 3 | N/A | N/A |
| Minority Interests | 10 | 11 | 14 | 57 | 29 |
| Net Income | $-2,557 | $404 | $-696 | $-715 | $-1,361 |
| EPS Basic Total Ops | N/A | 0.09 | -0.24 | -0.30 | -0.60 |
| EPS Basic Continuous Ops | N/A | 0.10 | -0.24 | -0.30 | -0.60 |
| EPS Basic Discontinuous Ops | N/A | -0.01 | 0.00 | N/A | N/A |
| EPS Diluted Total Ops | N/A | 0.09 | -0.24 | -0.30 | -0.60 |
| EPS Diluted Continuous Ops | N/A | 0.10 | -0.24 | -0.30 | -0.60 |
| EPS Diluted Discontinuous Ops | N/A | -0.01 | 0.00 | N/A | N/A |
| EBITDA(a) | $-2,469 | $-1,010 | $-696 | $-744 | $-1,306 |